1
Introduction
Demand
for accessible and affordable healthcare for infectious
and chronic diseases present significant challenges for providing
high-value and effective healthcare. Traditional approaches are expanding
to include point-of-care (POC) diagnostics, bedside testing, and community-based
approaches to respond to these challenges.
1
Innovative solutions utilizing recent advances in mobile technologies,
nanotechnology, imaging systems, and microfluidic technologies are
envisioned to assist this transformation.
Infectious diseases
have considerable economic and societal impact
on developing settings. For instance, malaria is observed more commonly
in sub-Saharan Africa and India.
2
The societal
impact of acquired immune deficiency syndrome (AIDS) and tuberculosis
is high, through targeting adults in villages and leaving behind declining
populations.
3
In resource-constrained settings,
it is estimated that about 32% of the disease burden is from communicable
diseases such as respiratory infections, AIDS, and malaria, while
43% of the burden is from noncommunicable diseases, such as cardiovascular
diseases, neuropsychiatric conditions, and cancer.
4
Developing diagnostic platforms that are affordable, robust,
and rapid-targeting infectious diseases is one of the top priorities
for improving healthcare delivery in the developing world.
5
The early detection and monitoring of infectious
diseases and cancer through affordable and accessible healthcare will
significantly reduce the disease burden and help preserve the social
fabric of these communities. Further, improved diagnostics and disease
monitoring technologies have potential to enhance foreign investment,
trade, and mobility in the developing countries.
6
Highly sensitive and specific lab assays such as
cell culture methods,
polymerase chain reaction (PCR), and enzyme-linked immunosorbent assay
(ELISA) are available for diagnosis of infectious diseases in the
developed world. They require sample transportation, manual preparation
steps, and skilled and well-trained technicians. These clinical conventional
methods provide results in several hours to days, precluding rapid
detection and response at the primary care settings. Another diagnostic
challenge is identifying multiple pathogens. Since common symptoms
like sore throat and fever can be caused by multiple infectious agents
(e.g., bacteria and viruses), it is important to accurately identify
the responsible agent for targeted treatment. Therefore, high-throughput
sensors for multiplexed identification would help improve patient
care.
7
Medical instruments in centrally
located institutions in the developed
world rely on uninterrupted electricity and running water and require
controlled environmental conditions. It may not be viable to satisfy
some of these criteria in some POC settings, where well-trained healthcare
personnel are not available and clean water access is unreliable.
7,8
Further, in remote settings without infrastructure, rain and dust
can act as contaminants.
7
Diagnostic devices
for POC testing in these settings are identified by the World Health
Organization to be affordable, sensitive, user-friendly, specific
to biological agents, and providing rapid response to small sample
volumes.
9
Optical biosensor devices are
emerging as powerful biologic agent detection platforms satisfying
these considerations.
10
Optical sensing
platforms employ various methods, including refractive
index change monitoring, absorption, and spectroscopic-based measurements.
11
Optical sensors that are based on refractive
index monitoring cover a range of technologies, including photonic
crystal fibers, nano/microring resonator structures, interferometric
devices, plasmonic nano/micro arrays, and surface plasmon resonance
(SPR)-based platforms.
11,12
The latter two are plasmonic-based
technologies. Plasmonics is an enabling optical technology with applications
in disease monitoring, diagnostics, homeland security, food safety,
and biological imaging applications. The plasmonic-based biosensor
platforms along with the underlying technologies are illustrated in
the Figure 1. Here, we reviewed SPR, localized
surface plasmon resonance (LSPR), and large-scale plasmonic arrays
(e.g., nanohole arrays).
Figure 1
Plasmonic-based technologies for versatile biosensor
applications.
SPR stands for surface plasmon resonance, LSPR for localized surface
plasmon resonance, SPRi for surface plasmon resonance imaging, and
SERS for surface-enhanced Raman scattering.
The integration of plasmonics and microfluidic technologies
can
potentially serve the global health, primary care, and POC applications,
offering modalities toward inexpensive, robust, and portable healthcare
technologies. Convergence of optical technologies and microfluidic
systems is promising for sensor applications by exploiting fluorescence
detection, absorption, transmission, and polarization measurements
on lab-chip (LOC) systems.
13
Microfluidics
manipulates fluids on the microscale, minimizing the use of expensive
reagents. Further, inexpensive microchip fabrication potentially allows
mass production.
3a,14
Along with the capabilities of
sample enrichment, isolation, mixing, and sorting, microfluidics has
provided applications in several fields, including molecular biology,
biotechnology, and defense.
15
These characteristics
ideally position microfluidics in conjunction with plasmonic technologies
to provide medical solutions at the POC and the primary care settings.
LOC devices can potentially address the challenges encountered
at POC settings.
7
In these devices, single-use
chips retaining the waste can be disposed of after use, avoiding contamination.
The LOC system can be built from relatively inexpensive parts, specific
to the disease and easy-to-operate with minimal training. The system
can be designed to be portable, safe, and battery powered. Integrated
microfluidic technologies with optical detection platforms such as
SPR have the potential to satisfy characteristics for inexpensive,
robust, and sensitive biosensors.
Here, theory and applications
of plasmonic-based platforms and
integration of these technologies with microfluidics are reviewed
from a POC diagnostics and monitoring perspective. First, we compare
the plasmonic-based biosensors with other optical, electrical, or
electro-mechanical biosensor technologies. We describe the theories
of SPR and LSPR and demonstrate the main experimental architecture
and operational modes currently employed. We then discuss in detail
the integration of microfluidic platforms, plasmonic technologies,
and surface chemistry techniques leading to LOC devices. We present
the current state-of-the-art plasmonic-based LOC biosensors. Finally,
we provide a perspective on the future of plasmonic technologies for
diagnostics and monitoring of different types of diseases, including
infectious diseases and cancer, at the POC and primary care settings.
2
Overview of Biosensing Technologies
Biosensors have
several crucial components: (i) a recognition element
that interacts with the target; (ii) a transducer that relates the
interaction of the recognition element and the target to a readable
electrochemical, optical, acoustic, or piezoelectric signal; and (iii)
a read-out system to interface with this signal.
16
SPR, surface-enhanced Raman scattering (SERS), whispering-gallery
modes (WGM), reflectometric interference spectroscopy (RIfS), and
photonic crystals (PC) provide robust and sensitive optical biosensor
platforms. Micro-electro-mechanical systems (MEMs) or electrical methods
also reach to low detection limits. In particular, cantilever-based
sensor technologies, such as atomic force microscope (AFM), and electrical
sensors, such as electrochemical impedance spectroscopy (EIS), are
alternative detection techniques for biosensing applications.
SPR and LSPR technologies are based on the wave propagation or
electromagnetic field enhancement phenomena near metal surfaces or
nanoparticles. The propagating surface plasmon polaritons excited
on plane metal surfaces are utilized in SPR sensors. LSPR relies on
the field enhancement and confinement in close proximity to nanoparticles.
The localized field oscillations around nanoparticles motivate the
name “localized” in LSPR. The plasmon modes extend up
to a couple of hundred nanometers into the biosensor medium in propagating
surface plasmon polaritons (PSPP) and up to a few tens of nanometers
in LSPR sensors, allowing sensitive subwavelength biosensors.
17
SPR biosensors interrogate the resonance angle
changes to detect and quantify bioagents. LSPR measurements are in
the form of absorbance or spectral shift data obtained from extinction
curves. In general, sensitivities of these resonance or extinction
shifts to refractive index changes are used to quantify figure of
merit parameters for SPR and LSPR sensors.
18
SERS is a surface spectroscopic method providing sensitive
biosensor
applications, and it is also a plasmonic technique, since one of the
physical mechanisms behind it is LSPR.
19
In SERS, the total enhancement factor arises from (i) LSPR-enhanced
Raman scattering and (ii) chemical enhancement factor.
20
Experimental biosensing demonstrations of SERS
include detection of bacteria,
21
viruses,
22
DNA,
23
proteins,
24
and other small biomolecules.
25
Single molecule detection has been achieved using SERS
technology.
26
The method interrogates Raman
shifts originating from molecular vibrational energy levels, and therefore,
allowing to distinguish structurally similar molecules if they have
distinct vibrational spectra. Experimentally, the utilization of fiber
optics and optofluidics, along with the use of portable spectrometers,
holds potential for future label-free POC applications.
27
RIfS, a spectroscopic method, monitors
the reflected white light
from thin transparent layers.
28
The reflected
light from each consecutive thin layer acquires a phase shift and
the resulting interference shows peaks and valleys as a function of
wavelength. When bioagents attach to the surface, the constructive
and destructive interference pattern of the reflected light changes.
This effect can be used to monitor real-time binding events. This
label-free technology has been used to detect cancer cells,
29
oligonucleotides,
30
and glycoproteins
31
and to acquire kinetic
analysis of binding events.
32
Another
label-free, sensitive optical biosensor is based on the
WGM technology. In this approach, tunable laser light is usually coupled
to microresonators (e.g., ∼100 μm diameter silica microspheres)
through a fiber. Part of the incoming light is guided along the circumference
of the resonator. If the light returns back in phase after every revolution,
the guided wave will drive itself coherently, resulting in a resonance
that can be measured as a dip in the transmission spectra. Bioagents
that are in close proximity of the sensor surface cause this spectral
dip to shift. This wavelength shift can be utilized in pathogen, DNA,
and protein detection applications.
33
Single
molecule detection is also demonstrated in modified WGM experiments.
34
Recently, PC technology is being utilized
for biosensing applications.
The PCs have a photonic band gap emanating from the periodicity of
the dielectric mediums.
35
Light cannot
be coupled to the PCs in the band gap corresponding to a range of
wavelengths. For instance, when light is incident on a one-dimensional
PC, there will be a narrow spectral window with full reflection. Particles
that are attached to the PC surface shift the position of this resonance
band.
36
The spectral location of the band
gap can be engineered by designing the periodicity of dielectric materials
in the PC and by carefully selecting refractive indices of these materials.
PC biosensors have been developed for label-free detection of bioagents
including viruses,
37,ref38
nucleic acids,
38
proteins,
39
and cancer
cells.
40
Electrical and micro-electro-mechanical
sensors provide alternatives
to optical sensing methods. EIS, an electrical sensing technology,
characterizes the frequency response of the impedance of a chemical
system.
41
In biosensor applications, target
analytes can be captured on the sensing electrode and the binding
events can be recognized as capacitive changes on this electrode.
Using surface modified electrodes, various EIS detection experiments
have been performed, including those on cells,
42
nucleic acids,
43
bacteria,
44
proteins,
45
and DNA–analyte
interactions.
41
EIS was recently used in
human immunodeficiency virus (HIV) detection, where viral load is
a maximum (106–108 copies/mL), through
electrical sensing of viral lysate.
46
This
label-free method selectively captures multiple HIV subtypes through
anti-gp120 polyclonal antibodies immobilized on the surface of streptavidin-coated
magnetic beads and detects the captured viruses through viral lysate
impedance spectroscopy on-chip. Electro-mechanical cantilever-based
technologies are primarily used for subnanometer level imaging as
well as in label-free biosensing.
47
Label-free
cantilever-based biosensors have been developed for detection of eukaryotic
cells,
48
mRNA biomarkers,
49
protein conformations,
50
and
DNA hybridization.
51
Single bacteria and
single nanoparticle detection is also shown by utilizing resonators
of microfluidic channels.
52
In Table 1, we review these biosensor technologies
along with the SPR technology, taking into consideration the detection
limit, practicality, and multimodality parameters. Many of these technologies
are close to or at the single molecule detection level, and the application
needs to be evaluated when choosing the appropriate biosensor platform.
Table 1
Comparison of Biosensing Technologies
Considering Their Underlying Physical Mechanisms, Multiplexing Capabilities,
and Limit-of-Detection Parameters
technology
physical
mechanism
portability
for POC
multiplexing
specificity/analyte
limit of
detection
ref
SPR
optical
high
sensing and imaging
bulk solution
(1–2.5) × 10–8 RIU
(53)
microfluidics
bacteria
∼104–107 CFUs/mL
(54)
LSPR
optical
high
possible to be combined
with microfluidics
human immunodeficiency virus
∼100 copies/mL
(55)
SERS
spectroscopic
moderate
possible to be combined
with spri
Rhodamine
6G and Crystal
Violet dyes
single
molecule
(26b, 56)
RIfS
optical
moderate
multiwell plates
antigen–antibody
interactions
19 ng/mL
(57)
chemical sensing
thrombine
1.5 pg/mm2
(58)
WGM
optical
moderate
polarization multiplexing
interleukin-2 (IL-2) cytokine molecule
single molecule
(34)
PC
optical
moderate
microfluidic integration
porcine rotavirus
36 virus focus forming units (FFU) or 0.18 × 104 FFU/mL
(37)
EIS
electrical
high
impedance imaging
proteins, antigens, nucleic
acids, antibodies
1–10 fM
(43b, 59)
human immuno-deficiency
virus
106 copies/mL
(46)
AFM
electro-mechanical
moderate
simultaneous imaging and
probing
ligands,
streptavidin–biotin
interactions
individual
molecular interactions
(60)
3
SPR Detection
Methods
3.1
Fundamental Optical Mechanisms of SPR
To analyze the propagation of surface plasmons along a metal–dielectric
boundary, we consider the reflection and refraction of light between
two infinite media. A linearly polarized, monochromatic light propagates
from the dielectric medium toward the metallic surface, as shown in
Figure 2. To explain the SPR theory, transverse
magnetic (TM) polarized incident light is used. TM polarization indicates
that the magnetic field vector is in the plane of the metal−dielectric
interface. There is no loss of generality in using TM polarization,
since transverse electric modes cannot excite surface plasmons.
61
Figure 2
Plane-wave, refracting, and reflecting light at a metal–dielectric
interface. n
2 and n
1 are the refractive indices of the metal and the dielectric
mediums. E is the electric field vector, B is the magnetic field vector, and k is
the wavevector.
The indices i, r, and t are for incident, reflecting and refracting
light. The magnetic field is perpendicular to the plane of incidence,
representing transverse magnetic (p-polarized) light.
Solving Maxwell’s equations for the p-polarized
light for
the wavevector components, one can find the surface plasmon dispersion
relation,
62
1
Here, the medium is indicated
by the first
subscript (i.e., i = 1 for dielectric medium and i = 2 for metal medium), the axis
is indicated by the second
subscript, k is the wavevector, ω is the angular
frequency of the light, c is the speed of light in
vacuum, n
2 and n
1 are the refractive indices for the metal and the dielectric
media, respectively, ε1 = n
1
2, ε2 = n
2
2, and ε1 and ε2 are the dielectric constants of the media. From the boundary conditions
it also follows that k
1z
= k
2z
. Since medium
2 is a metal, the dielectric constant ε2 and k
ix
are complex-valued quantities,
resulting in the exponential decay of the plasmon field in both media,
in the direction of the x-axis. This decay results
in a surface wave, confined to the metal–dielectric interface.
Physically, the incident photons couple to the free electrons on the
interface, resulting in a propagating surface charge-density oscillation.
The k
1z
component of
the wavevector defines the wavelength of the resonance oscillation
and also the extent of the plasmon wave over the interface before
absorption by the metal. For long-range and bound plasmon waves in
an ideal, lossless medium, a real-valued k
1z
and an imaginary-valued k
ix
are required, i.e. ε1ε2 < 0 and ε1 + ε2 <
0, ignoring the imaginary parts of the dielectric constants. At optical
wavelengths these two conditions are satisfied for gold and silver,
which are commonly used metals in SPR experiments.
63
Field components of the plasmon modes take their
highest values
at the interface and exponentially decay into the metal and dielectric
media. The penetration depth of the fields into both mediums are given
by 1/Im(k
1x
) and 1/Im
(k
2x
), where Im is the
imaginary part.
62
The penetration depth
in the dielectric media is on the order of half the wavelength of
the incident light. For instance, for a gold–water interface
and λ = 700 nm, the penetration depth in water can be calculated
to be around 238 nm.
62
When there
is a local change in the dielectric constant over the
metal layer, which is caused by a molecular binding event, the surface
plasmon mode energy will be changed. The SPR biosensors rely on this
property of the resonance. Since the total energy of the system is
conserved, the change in the plasmon mode’s energy will leave
a signature on the reflected or transmitted light. In SPR biosensor
applications, light is monitored and analyzed to extract binding and
kinetic information. This analysis is related to which method is utilized
to couple the light to plasmon modes. In the following section, we
overview the main light coupling methods to surface plasmon modes.
3.2
Light Coupling Methods
To excite
surface plasmons on a metal–dielectric interface, the incident
light needs to provide photons that would satisfy the energy and momentum
conservation laws in the light–metal system. More specifically,
the incident photon’s momentum and energy should match to the
momentum and energy of the plasmon modes to be able to excite these
charge-coupled oscillations. The preceding conditions for plasmon
generation can be satisfied simultaneously only when an optical coupling
element is added to the system shown in Figure 2. The common light coupling techniques
utilized for this purpose
are prism, grating, and waveguide coupling methods among other techniques
such as waveguide, photonic crystal, and fiber-optic based coupling.
64
Physically, these modifications take advantage
of attenuated total reflection (ATR), light diffraction, or evanescent
wave coupling from waveguide modes in these applications.
65
3.2.1
Prism Coupling
Otto configuration
and Kretschmann configuration are the pioneering methods of prism
coupling for SPR excitation.
66
In these
configurations, a second dielectric layer (a prism) is added to the
two-level system design considered previously, forming two interfaces.
In the former case, a dielectric layer is sandwiched between a metal
layer and the prism.
67
In the latter case,
the metal layer is sandwiched between a prism and the sensing medium.
68
A biosensor setup in the Kretschmann configuration
is shown in Figure 3. The addition of a prism
provides the necessary modification in the dispersion curves for photon-plasmon
coupling. If the prism dielectric constant ε3 is
chosen such that ε3 > ε1, it
is
possible to satisfy the energy-momentum conservation laws for the
incident light and plasmon modes, allowing for surface plasmon excitation
on the metal–sensing medium interface.
69
The energy–momentum conserving equation in the Kretschmann
configuration then takes the following form
2
where k
z
is the wavevector for the
surface plasmon modes at the metal–sensing
medium interface. Analogous equations for different coupling mechanisms
are summarized in Table 2. For a given light
frequency ω, the incidence angle that satisfies this equation
is called the plasmon resonance angle. At this particular resonance
angle, the incoming light transfers most of its energy to the plasmon
modes, so the reflectivity approaches to zero at this angle.
70
The resonance angle is sensitive to small changes
of the refractive index over the metal–dielectric interface.
This property enables construction of biosensors that convert the
shifts in the resonance angle to quantitative binding data. For instance,
Figure 4A illustrates the use of a biosensor
in the Kretchmann configuration with a microfluidic chip.
Table 2
SPR Coupling Methods and Coupling
Equations
coupling
method
coupling equationa
equation
parameters
prism coupling (Kretschmann
configuration)
ε3 is the
dielectric constant of the prism, c is the speed
of light, ω is the angular frequency of the light, and α
is the incidence angle
waveguide coupling
βwaveguide is the propagation constant for the
waveguide mode.
grating coupling
Λ is the grating period, k
0 is the component of the incident light parallel
to the interface, and m is the grating order.
a
k
z
is the
wavevector for the surface plasmon modes at the metal-sensing
medium interface. Re{} indicates the real part of the argument.
Figure 3
A biosensor design in the Kretschmann configuration
is shown. The
metal surface (e.g., gold) is functionalized with selective/specific
recognition elements, for instance with antibodies. Transverse magnetic
polarized incident light is coupled to the surface plasmon modes on
the metal–sensing medium interface. The plasmon waves propagate
in the immediate vicinity of the interface. When the chemically activated
metal surface captures biological samples, the resulting refractive
index change on the surface will modify the surface plasmon modes.
These binding events will leave a signature in the reflected light,
which is detected by a detector [e.g., a charge-coupled device (CCD)]
for analysis.
Figure 4
Most common surface plasmon
operation modes for light coupling:
(A) Kretschmann configuration for prism coupling, (B) waveguide coupling,
(C) fiber-optic based coupling, (D) grating coupling, (E) planar waveguide
photonic crystal coupling, (F) honeycomb photonic crystal coupling,
(G) waveguide-based coupling in Kretchmann configuration.
3.2.2
Waveguide Coupling
Waveguide structures
can be used for coupling light to excite surface plasmons (Table 2). A generic waveguide
coupling device model is
shown in Figure 4B. The propagating wave intensity
in the waveguide is concentrated in the planar waveguide structure,
while a small portion of the light extends through the metal layer
to the metal–sensing medium interface and induces surface plasmons.
This phenomenon is realized in a narrow wavelength range (resonance
wavelength) and presents itself in the transmitted light spectra.
71
Therefore, the wavelength spectra at the output
port of the waveguide can be monitored for biosensing applications.
The shift of the resonance wavelength will allow quantification of
the captured agents.
72
Fiber-optic-based
coupling approach provides a special case of this method that the
fiber-optic cables are cylindrical optical waveguides working with
total internal reflection principle. Figure 4C shows a generic fiber-coupled SPR device.
The propagating light
bounces from the higher refractive index cladding while propagating
in the lower refractive index core of the fiber. A portion of the
cladding can be removed and coated with a thin metal layer which is
in contact with the sensing layer. The incident light on the metal
layer reaches to the metal–sensing layer interface as an evanescent
wave and induces surface plasmons on this interface.
73
3.2.3
Diffraction Grating Coupling
Two
dimensional metallic gratings can be used to couple light to plasmon
modes on interfaces. Figure 4D illustrates
a grating coupled biosensor operating in the transmission mode. The
momentum-matching condition becomes a function of the grating order m, an integer
value related to the diffracted light direction
(Table 2). Transmitted or reflected light from
grating coupled plasmonic biosensors can be studied under intensity,
wavelength, or angular interrogation.
74
3.2.4
Photonic-Crystal-Based Coupling
In recent years, new coupling methods have also been attracting attention.
Various PC-based sensors were realized with planar-waveguide fibers,
microstructured PC fibers, and PC Bragg fibers.
75
In the planar-waveguide structure, the core is covered
with a periodic PC structure (Figure 4E). One
side of the waveguide is gold coated and is in contact with the analyte
for plasmonic detection. The microstructured PCs are being explored
in several design alternatives.
76
In general,
the fiber is made of silica glass.
77
The
air-filled geometric holes provide the periodic structure for the
photonic crystal (Figure 4F). The semicircular
shapes are analyte filled microchannels. These channels are gold-coated
for surface plasmon excitation and detection. These technologies can
be used with microfluidics to provide integrated biosensors.
3.2.5
Combined Coupling Methods
A number
of the preceding methods have been proposed to be used together for
plasmonic biosensor architectures. One example is provided by the
prism-coupled waveguide plasmon excitation scheme.
78
In this method a polymer waveguide is sandwiched between
two metal layers (Figure 4G). A prism is used
to couple the incident light to plasmon modes on one of the metal
layers. The polymer waveguide can be electro-optically modulated to
a desired refractive index. This tuning of the waveguide-coupled surface
plasmon modes makes sensitive surface plasmon angle interrogation
possible by utilizing modulation and demodulation techniques.
3.3
Localized Surface Plasmon Resonance
LSPR
sensing is a spectroscopic technique based on the strong electromagnetic
response of metal nanoparticles to refractive index changes in their
immediate vicinity. When light is incident on nanoparticles, particular
electronic modes can be excited so that the conduction band electrons
oscillate collectively.
79
As a result of
these resonance oscillations, also called localized surface plasmons,
the nanoparticles strongly scatter light at a specific wavelength
range. The plasmon oscillations obtained by solving Maxwell’s
equations around metal nanoparticles are illustrated in Figure 5.
80
The sum of light
scattering and absorption is called extinction, and it is possible
to observe the optical response of individual nanoparticles using
dark-field microscopy.
81
In biosensing
applications, the attachment of an analyte to these nanoparticles
results in a refractive index change, causing a red or blue shift
in the extinction peak wavelength, λmax. This shift
in λmax is given by the following equation
82
3
where m is the sensitivity
factor, Δn is the change in the refractive
index, d is the effective adsorbate layer thickness,
and l
d is the electromagnetic field decay
length. The extinction is maximized by optimizing the nanoparticle
characteristics described by m and l
d, and it is already well-established that the extinction
is a strong function of the nanometal’s type, size, shape,
and orientation.
83
Exploitation and design
of these parameters will be essential for new effective LSPR applications.
83
Figure 5
Electric fields around nanoplasmonic silver particles.
(A) Illustration
of the plasmon oscillation and the electron cloud on metal spheres.
(B) Electric field contours of the main extinction peak 30 nm silver
spheres in vacuum. Cross section of the sphere is shown with 369 nm
light. (C) Electric field contours on 60 nm radius silver spheres
in a vacuum. A cross section of the sphere is shown with 358 nm light
and the field is from the quadropole peak. Adapted with permission
from ref (80). Copyright
2003 American Chemical Society.
LSPR sensing experiments utilize a white light source covering
the visible spectrum.
84
The scattered light
is collected with a spectrometer, and changes in the spectra are then
converted to binding data.
79
In these experiments,
light is directly coupled to the sample without requiring a prism
or a grating, as in the SPR technique; therefore, the angle of incidence
does not need to be precisely controlled. In contrast to the SPR technique,
LSPR sensors based on nanoparticle surfaces are less sensitive to
thermal variations.
18a,64,85
In addition, with the availability of portable spectrometers, it
is likely that LSPR applications can be translated for portable diagnostic
applications.
3.4
Nanoplasmonic Arrays
Array-based
nanoplasmonic detection is a plasmonic technique, similar to SPR imaging
(SPRi) in the sense that it can be used for high-throughput biosensing
applications. Various nanoplasmonic arrays have been demonstrated
for refractive-index-based sensors, including nanoholes,
86
nanowells,
87
nanoposts,
88
nanopillars,
89
nanorods,
90
nanodisks,
91
nanotubes,
92
and nanopyramids.
93
These periodic arrays present high reproducibility in sensor fabrication,
allow spectroscopic and intensity based measurements, and have a small
footprint. A number of fabrication techniques are used for large-scale
arrays, including focused ion beam milling and soft lithography techniques.
94
However, they require expensive fabrication
methods that are not suitable to create inexpensive devices.
Nanohole arrays are usually made from perforated metal films supported
on substrates such as silicon nitrides. These arrays are based on
the extraordinary optical transmission (EOT) effect
95
and find applications as refractometric sensors.
96
In nanohole arrays, localized and propagating
SPR modes are intercoupled.
97
The resulting
resonance modes are influenced by the periodicity, size, and shape
of holes in the array and the composition of materials used in the
sensor.
96a,98
Extensive numerical calculations have been
used to gain insight for the optimization of these parameters.
99
These periodic arrays can be used in the flow-through
geometry in biosensors, which enables concentrating analytes under
applied electric fields (Figure 6).
100
This operation mode lets analytes pass through
the nanochannels, which are also forming the plasmonic structure of
the sensor, and was shown to improve mass transport properties and
response time.
86
Figure 6
A nanohole array integrated
with fluidics. The flow-through plasmonic
nanostructure enabled local concentration of analytes. The method
presented 100-fold concentration and simultaneous sensing of a protein.
Further, the method presented 10-fold improvement in sensing speed
in comparison to the control experiment with no analyte concentration.
Reprinted with permission from ref (100a). Copyright 2012 American Chemical Society.
From a POC perspective, combination
of array-based sensors with
microfluidic chips can allow high-throughput sensors. Since each array
can be interrogated separately and multiple arrays on parallel microchannels
can be fabricated, nanohole array sensors are suitable for multiplexed
on-chip detection. Light can be coupled directly to the sensor at
or close to normal incidence, and the transmitted light can be interrogated
with a CCD sensor.
101
The imaging mode
permits use of high numerical aperture optics, allowing wide-field
imaging from densely packed arrays.
102
Microfluidic
integrated nanohole arrays have been used for analyzing antibody–ligand
binding kinetics
103
and biomarkers.
100b
A recent application of nanoholes incorporated
50 microfluidic channels (30 μm width, over a 3.5 × 2 mm
area) and utilized high-throughput SPR imaging.
104
The system was used for real-time affinity measurements.
Capture of intact viruses has been earlier shown from unprocessed
whole blood on microchips.
105
Nanoholes
have potential to be used in optofluidic biosensor applications, as
recently demonstrated in the detection of pseudoviruses (i.e., pseudotyped
Ebola virus) and intact Vaccinia virus at 108 pfu/mL in
PBS.
106
However, this platform needs to
be expanded to detect viruses from bodily fluids at clinically relevant
concentrations for diagnostic applications.
4
Integration of Plasmonic Technologies with Microfluidics
The integration of microfluidics and plasmonics brings the capability
to build label-free and reliable biosensors on a LOC platform. Microfluidics
has been widely used in cell separation and isolation and preparation,
analysis, and delivery of samples.
84,107
In particular,
microfluidic technologies for blood cell separation and plasma isolation
are significant for clinical applications.
108
Integrated microfluidic devices with various fluid manipulators
including pumps, mixing systems, separators, and valves have already
been demonstrated.
109
Complete processing
and analysis of various bioagents have been shown on LOC microfluidic
devices.
110
For instance, DNA purification
from bacteria on a single microfluidic chip has been shown without
either pre- or post-sample processing.
111
Combining microfluidics with optics provides a rapidly expanding
range of applications by bringing advantages from these fields. Microfluidic-based
plasmonic devices are refractive index monitoring type devices. This
class of devices can be considered as a subtype of optofluidics devices.
On one hand, light can be used to direct the motion of fluids in microfluidic
chips. Optical-tweezers-based approaches have been used to build valves
and pumps to induce flow in microfluidic channels.
112
Blood cell separation has been demonstrated by utilizing
optical lattices.
113
On the other hand,
fluids can be used to alter optical parameters, as in plasmonics.
Refractive index, absorption, polarization, and spectral properties
can be monitored for various plasmonic biosensor designs. A further
advantage of plasmonics is to allow label-free signal transduction
method.
The two main optical biosensor design considerations
are light–analyte
interaction volume and sample delivery, which can seriously constrain
the use of biosensors. The former consideration can be addressed by
plasmonics taking advantage of the evanescent electromagnetic fields.
For instance, the evanescent fields generated by the surface plasmon
polaritons in SPR extend a few hundred nanometers into the fluid and
allow low analyte densities to be detected. The latter consideration
can be addressed by microfluidics, which can manipulate microliter
quantities of fluids.
114
Further, selective
delivery of analytes through multiple channels can be engineered for
high-throughput microfluidic applications.
In plasmonic-based
LOC biosensors, a recognition element is immobilized
on the detection surface for label-free sensing. The choice of the
recognition element depends on a number of factors, including the
specificity and affinity toward the target molecule. Further, the
complex formation between the recognition element and the target molecules
should be stable in structure. Various surface functionalization techniques
exist for the immobilization of these moieties for stable, high-density
and efficient binding. We review these techniques in the following
section.
4.1
Surface Functionalization
Biosensing
platforms are comprised of a sensing support surface (e.g., gold and
silver) and an immobilized biomolecular recognition element (e.g.,
antibodies, oligonucleic acids, peptide nucleic acids, peptides, and
polymers).
115
The support surface enables
the recognition element to be stable and allows them to interact with
the target analytes. Depending on the sensitivity, specificity, and
limit of detection, the recognition element is immobilized through
several surface techniques, including physical adsorption, chemical
adsorption, covalent binding, and affinity-based interactions.
115a
Besides these common methods, recent advances
in surface functionalization and antifouling agents to minimize nonspecific
binding are also reviewed in the following subsections.
4.1.1
Physical Adsorption
Physical adsorption
technique utilizes the surface characteristics and surface charge
to attach and immobilize biorecognition elements onto the surface
and relies on nonspecific physical interactions between the recognition
element and the support material.
116
In
contrast to chemical binding techniques, this method also holds a
key advantage since it does not require any reagent to activate chemical
groups on the surface, and thus, this technique is easy to perform,
inexpensive, and reduces structural damage in biorecognition elements.
The physical adsorption method particularly utilizes hydrogen bonding
and van der Waals forces.
117
These weak
interactions also allow the biorecognition elements to easily detach
from the surface, and thus, the biosensing surface can be used multiple
times. However, nonspecific physical interactions are closely affected
by environmental changes, including temperature, ionic content, and
pH. On the other hand, this technique causes nonspecific binding of
other molecules and substances, resulting in a significant decrease
in surface coverage of the recognition elements and sensor specificity.
The support materials can be modified to generate surface charge
and reactive groups using oxidizing techniques such as oxygen plasma
treatment. Oxygen-plasma-treated and untreated polystyrene (PS) slides
have been recently used as sensor substrates to detect breast cancer
type 1 (BRCA1) gene mutations, and these two cases were compared in
terms of uniform immobilization and binding capacity of a biorecognition
element (i.e., oligonucleotide–protein conjugate).
118
On plasma-treated slides, the binding amount
of oligonucleotide–protein conjugates significantly increased
compared to untreated slides.
118
Another
interesting observation in this study was that plasma treatment amplified
the surface area and formed nanoroughened structures that could facilitate
detection of a low amount of target analyte and improve the analytical
performance of the biosensing surface in microarray applications.
118
Although oxygen plasma treatment is a simple
and effective method for many surfaces, it often causes significant
damage on the biosensing support surface.
119
This major obstacle leads to permanent surface disruptions, which
interfere with the sensor surface structure and reduce sensitivity.
119
On the other hand, the surface characteristics
(e.g., hydrophobicity and polarity) and the functional groups of biomolecules
determine the molecular interactions for biomolecule immobilization.
Although, in some cases, the orientation of the recognition element
is not critical to capture the target analyte, these molecular changes
on the surface can affect biomolecular activity (e.g., denaturation
of proteins) and orientation of proteins and antibodies due to the
restrictions in their conformational flexibility.
120
4.1.2
Chemical Adsorption and
Covalent Binding
Chemical adsorption and covalent binding
techniques are most frequently
combined to form chemical coupling and bond formation between support
surface and biorecognition elements in three main steps: (i) support
surface activation, (ii) functional group generation, and (iii) biomolecule
immobilization.
115a
The self-assembled
monolayer (SAM) technique, one of the most common chemical adsorption
techniques (i.e., chemisorption), spontaneously generates self-formation
of molecular assemblies on substrates.
121
N-alkylthiols or disulfides are the most common
SAM molecules, consisting of an alkyl backbone chain, thiol head,
and functional tail groups.
115a,122
On these molecules,
thiol head groups have strong affinity to bind to metal surfaces (e.g.,
gold and silver), and the alkyl backbone tethers the biomolecules
from the substrate. The latter group presents a functional end to
interact and covalently bind to biomolecules.
115a
Coupling reactions (e.g., N-hydroxysuccinimide
(NHS) and ethyl(dimethylaminopropyl)carbodiimide (EDC)) are the most
common biomolecule immobilization methods that typically form succinimide
groups that interact with amine groups of organic molecules (e.g.,
antibody, protein, nucleic acids, and amine-modified lipids).
123
By utilizing covalent bonding, modified SAM
agents (e.g., 11-mercaptoundecylamine (MUAM) and dithiobis(N-succinimidyl propionate)
(DTSP)) were previously used
to immobilize double-stranded DNA, peptide nucleic acid (PNA), and
miRNA on SPR gold sensors for the detection of nucleic acids.
124
Other than the SAM mechanism, biomolecules
can be immobilized through silanization agents (e.g., (3-aminopropyl)triethoxysilane
(APTES) and (3-aminopropyl)trimethoxysilane–tetramethoxysilane
(MPTMS or 3-MPS)) that cover a biosensing surface (e.g., glass, mica,
metal oxides, and silica) with functional alkoxysilane molecules by
forming a covalent Si–O–Si bond.
107c,125
This process can also be coupled with another reaction as performed
in SAM modifications.
107c,120,126
On the same platform, long- and short-chained SAMs can also be utilized
to block the surface from nonspecific binding.
127
Further, long-chained SAMs can be used to construct artificial
lipid bilayer systems using hydrophobic interactions between alkyl
backbones and lipid tails.
128
For instance,
artificial lipid bilayers are constructed by the rupture of liposomes,
and self-assembled hexadecane monolayer surface assists to rupture
liposomes for the formation of lipid bilayers on gold surfaces.
128
Thus, self-assembled hexadecane monolayer surface
provides a dynamic and stable structure to tether lipid bilayer and
allows for further biomolecular analyses such as polymer–lipid
bilayer interaction in vitro conditions.
128
Additionally, SAMs can be used to immobilize protein conjugate,
oligonucleic acids, and peptide nucleic acids for microarray analysis.
129
However, there are some limitations in SAM
formation, including availability of substrate, low number of organic
molecules for monolayer formation, the choice of anchoring groups,
and limited solubility of monolayer molecules.
121
Additionally, bulky monolayer molecules result in large
defects in monolayer structure and lack of thermal and oxidative stability
restricting their large-scale use in detection platforms.
121
4.1.3
Affinity-Based Interactions
Affinity-based
surface functionalization techniques address some of the current challenges
in biomolecule immobilization methods mentioned above. Avidin–biotin-based
interactions are commonly used to immobilize biomolecules (e.g., nucleic
acids, proteins, and antibodies) on the biosensing surface without
interfering with their biomolecular structure and function.
105b
For instance, NeutrAvidin and streptavidin
are well-known members of avidin proteins, and they have high association
capacity to biotinylated molecules such as antibodies, nucleic acids,
peptides, and PNA. An interesting example for biotin–avidin-based
surface functionalization is traptavidin, which is an engineered mutant
version of streptavidin protein according to biotin–4-fluorescein
dissociation rate.
130
This mutant avidin
protein has lower flexibility in the biotin-binding pocket, and this
structural property reduces the entropic energy required for biotin
binding.
130
Thus, traptavidin structurally
inhibits the dissociation rate and enhances thermostability compared
to native avidin proteins. Traptavidin is also a versatile protein
that can bind to a range of biotin conjugates (i.e., biotin–4-fluorescein,
biotin–amidocaproyl-BSA and biotinylated DNA (internal and
terminal)).
130
Therefore, this protein
holds a great potential to replace other avidin-based proteins in
nanoplasmonic detection platforms, molecular anchored arrays, and
POC diagnostic technology platforms.
130
However, the biotinylation site is a critical parameter for biomolecule
(e.g., antibody) orientation in avidin–biotin-based surface
chemistries. Two groups of affinity-based surface chemistries (i.e.,
protein G- and NeutrAvidin-based) were evaluated, and the observations
obtained from AFM demonstrate that protein G-based surface chemistry
can efficiently immobilize the antibodies with their favorable orientation
in microfluidic channels.
105b
Since protein
G has a specific binding site for the fragment crystallizable region
(Fc) of antibodies, it provides better control over antibody orientation.
105b
To increase the number of antibody binding
sites and stability, immunoglobin specific proteins are engineered
using recombinant DNA technology. Protein A/G is a notable example
of the recombinant antibody immobilization molecules that combines
IgG binding domains of both protein A and protein G. This recombinant
fusion protein is comprised of four Fc binding domains from protein
A and two from protein G, and it is more stable to pH changes compared
to protein A.
106,131
Overall, affinity-based surface
functionalization methods increase sensitivity and capture efficiency
and improve the detection limit to capture target molecules/bioagents
by utilizing high binding affinity and controlling molecular orientation.
Additionally, oligonucleotide immobilization for nucleic acid hybridization
studies and histidine-chelated metal ion methods for protein-based
detection are widely used in the immobilization of biorecognition
elements.
132
There are also new surface
functionalization methods, including polymeric coating, lipid bilayer
construction, PNA, and aptamer immobilization, to capture target analytes
in POC and primary care diagnostics for various applications ranging
from early cancer detection diagnosis and monitoring of infectious
diseases.
4.2
Blocking of Nonspecific
Binding
Nonspecific
binding to biosensing surfaces is one of the major drawbacks for specific
capture and quantitative analysis.
133
One
of the challenges is the concentration of other substances being higher
than target analyte since these substances can also bind/attach to
the biosensing area.
134
Although the binding
characteristics of nonspecific interactions is much different than
that for a specific binding event, nonspecific interactions and binding
still poses a significant bottleneck for limit-of-detection in biosensors.
Further, nonspecific binding can occur at functionalized, passivated,
and untreated regions of the biosensing area.
134
Thus, these nonspecific interactions can decrease detection
sensitivity. There are several antifouling agents (e.g., chemical,
protein based, and polymeric agents) used to address these challenges
by improving the specificity.
Thiol compounds have been commonly
used as chemical blocking agents on metal surfaces. The length and
terminal group of thiol compounds affect the sensitivity and detection
limit.
135
To evaluate these parameters,
a number of alkanethiol SAMs (i.e., 3-mercapto-1-propanol (3-MPL),
6-mercapto-1-hexanol (6-MHL), 8-mercapto-1-octanol (8-MOL), 9-mercapto-1-nonanol
(9-MNL), 11-mercapto-1-undecanol (11-MUL) and another blocking thiol
(C11) with a −CH3 terminating headgroup,
and 1-dodecanethiol (1-DDT)) was used for the detection of the target
DNA sequences using pyrrolidinyl peptide nucleotide acid (acpcPNA)
probes that were immobilized via a spacer molecule.
135
The blocking thiol compound with same length (9-MNL) as
the total spacer molecule provided the highest sensitivity [20.4 ±
0.7 nF cm–2 (log M)−1] compared
to the other thiol blocking agents with shorter and longer length.
135
This specific length possibly arranged more
favorable hybridization, resulting in the highest hybridization efficiency,
whereas the blocking agent with longer length overlapped with the
probe.
135
The terminal groups (i.e., −OH
and −CH3) of thiol blocking agents were also evaluated
on the same platform, and the hydroxyl-terminated agent provided a
slightly better sensitivity by increasing hydrophilicity for DNA immobilization
and hybridization.
135
Proteins (e.g., bovine
serum albumin, casein, glycine, and gelatin) have been also used to
protect the biosensing surface from nonspecific interactions. Instantized
dry milk, casein, gelatins from pig and fish skin, and serum albumin
were evaluated to understand the blocking capabilities, and casein
and instantized milk were observed to inhibit nonspecific binding.
136
In this study, porcine skin gelatin was observed
to be the least effective antifouling agent.
136
Overall, the critical parameter for protein blocking experiments
is that blocking agent (e.g., casein) primarily interacts with the
biosensing area instead of blocking the protein–protein interactions
observed in porcine skin gelatin experiments.
136
However, the efficiency of these natural blocking agents
(e.g., albumin, casein, and glycine) is not considerably satisfactory.
137
In contrast, polymeric blocking agents are
easily reproducible and can be modified to increase the specificity
of blocking.
137
Polyethylene glycol (PEG)
is one of the most common polymeric blocking agents, and a densely
packed PEG tethered-chain surface allows one to minimize nonspecific
binding.
137,138
The combination of long and
short PEG chains significantly reduces biofouling on the biosensing
surface and increases the sensitivity.
137,139
Factor IX
(FIX) was immobilized on glutaraldehyde-activated surface and detected
via its aptamer.
137
A copolymer (i.e.,
poly(ethylene glycol)-b-poly(acrylic acid) (PEG-b-PAAc)) was used as a blocking agent
to reduce nonspecific
binding on untreated and glutaraldehyde-activated regions.
137
The limit of detection was observed to be down
to 100 pM.
137
The sensitivity was further
improved by using dual polymers (i.e., PEG-b-PAAc
and pentaethylenehexamine-terminated PEG (N6-PEG)) on the same platform,
and 1000-fold better sensitivity (100 fM) was achieved with respect
to the blocking with PEG-b-PAAc.
137
Here, the use of dual polymers demonstrates higher sensitivity
and reliability for the biosensing platforms that detect a very small
amount of target molecules from complex fluids such as whole blood.
137
Apart from these surface modifications, the
generation of nanorough surfaces allows one to prevent the bacterial
attachment on biosensing surface.
140
4.3
Recent Advances in Surface Functionalization
Within the past decade, conventional surface functionalization
methods have been replaced with new surface modification materials
(e.g., lipids and polymers) and techniques (e.g., thiol exchange and
site-specific functionalization). These innovations improve the molecular
interactions between target molecule and the receptor of interest,
and they enable more stable structures for biosensing platforms.
141
For instance, receptors (e.g., integral proteins)
incorporated with cellular membranes require hydrophobic content to
conserve their native structure and function in biosensing platforms.
141c
Dynamic, flexible, and complex nature of the
cellular membranes is an attractive candidate to support biorecognition
elements such as receptors for these platforms.
141c
Noncovalent assembly of lipid bilayers on biosensing surfaces
combines highly sophisticated surface modification mechanisms with
a nature-synthesized functional platform.
141c
The arrangements of lipid bilayers also allow one to monitor membrane-associated
molecular recognition events on the close vicinity of the membrane
using surface sensitive tools such as LSPR and SPR.
141c
To construct lipid bilayers on biosensing platforms, specific
surface immobilization strategies are employed using tethering agents
that rupture lipid vesicles to form a planar lipid bilayer.
141b,142
This strategy can be done by utilizing a thin layer of SiO2 on plasmonic substrate.
143
Other construction
strategies are the use of thiolated lipids that covalently immobilize
lipid membrane to metal substrate and utilization of a polymer cushion
that tethers lipid membrane and forms an ionic reservoir for functional
integration of receptors.
144
Chemical
modification and physical properties of lipid molecules have allowed
lipid bilayers to be used in surface sensitive biosensing approaches,
including the detection of biomolecules, proteins, and nucleic acids.
Biotinylated-lipid membranes were immobilized to detect streptavidin
molecules on the surface of gold nanorods by monitoring the spectral
shifts using a fast single particle spectroscopy (fastSPS) instrument
coupled with dark-field microscopy (Figure 7A(i)).
145
The binding of streptavidin
molecules to a single nanorod resulted in a median shift of 2.9 ±
1.8 nm when 29 nanorods were analyzed.
145
Thus, on this platform, local interactions of proteins with cellular
membranes could be monitored in real-time.
145
Another interesting example was to assess the binding of target
proteins to supported lipid-membrane-coated nanocubes (Figure 7A(ii)).
146
Here, the
researchers reported a solution-phase plasmonic sensor method that
utilizes LSPR spectra of Ag@SiO2 core shell nanocubes using
spectroscopic measurements (Figure 7A(ii)).
146
In this work, supported lipid bilayers were
spontaneously formed by mixing Ag@SiO2 core shell nanocubes
in lipid-vesicle solution, and the plasmonic response of the platform
was calibrated by examining the binding of streptavidin to biotinylated
lipid molecules in the supported membrane. LSPR response was then
converted to protein coverage on the nanocube surface by utilizing
the LSPR shifts to protein mass change, and the limit of detection
was reported as 0.191 ng/mm2 nm.
146
Further, cellular-membrane-associated molecular interactions were
assessed on the supported lipid-bilayer-modified gold nanoparticles
using a single nanoparticle tracking-based detection method.
147
The binding and molecular interactions of membrane-associated
molecules (i.e., cholera toxin B subunit and ganglioside GM1 pentasaccharide
head-groups) were evaluated using the diffusion coefficients of gold
nanoparticles on the membrane.
147
The limit
of detection for the cholera toxin B subunit was observed to be down
to 10 pM, resulting in 100-fold improvement in the sensitivity compared
to fluorophore-based methods.
147
Thus,
an ultrasensitive detection platform was developed by utilizing the
mobility of lipid molecules in membranes.
147
Additionally, supported lipid membranes were employed on nanopore
assays for the detection of small molecules (e.g., proteins) and the
monitoring of DNA hybridization and receptor–target interactions.
141c,148
The integration of lipid bilayers with nanohole platforms facilitated
more frequent translocation/mobility of target molecules and, thus,
introduced chemical sensitivity and avoided clogging, which are major
obstacles in biosensing assays (Figure 7A(iii)).
141c,149
Overall, lipid-bilayer-incorporated biosensing platforms improve
the molecular interactions and form a support layer for the integration
of biorecognition elements. Thus, this new surface functionalization
strategy can be used for membrane-associated molecule biosensors and
toxin/drug screening assays in the future.
Figure 7
Recent advances in surface
functionalization methods and materials.
(A) Lipid-supported surface functionalization and applications: (i)
Schematic of a gold nanorod coated with a biotinylated lipid membrane
and interactions with streptavidin. Adapted with permission from ref (145). Copyright
2008 American
Chemical Society. (ii) Schematic of supported lipid-bilayer-coated
core shell nanocubes (Ag@SiO2). TEM images of whole and
select region of a Ag@SiO2 nanocube. A solution-phase plasmonic
sensor measures LSPR spectra of surface modification and coating on
Ag@SiO2 core shell nanocubes using a standard laboratory
spectroscopy. Adapted with permission from ref (146). Copyright 2012 Nature
Publishing Group. (iii) Schematic of lipid-bilayer-coated nanopore
in silicon nitride substrate. This platform facilitates mobility of
target molecules and minimizes clogging. Adapted with permission from
ref (149). Copyright
2011 Nature Publishing Group. (B) Lipid-supported surface functionalization
and applications: (i) The procedure of a gold-nanoparticle-hybridized
polymer film for biosensing applications. Adapted with permission
from ref (150). Copyright
2009 Wiley-VCH Verlag GmbH & Co. KGaA. (ii) SPR-based biosensing
platform with embedded indium tin oxide microheater and rapid tuning
of SPR signal using a thermoresponsive polymer (i.e., pNIPAAm). Reprinted
with permission from ref (151). Copyright 2013 American Chemical Society. (C) Surface
functionalization on patterned surfaces: (i) Schematic and scanning
electron microscopy (SEM) image of the patterned nanostructures (i.e.,
nanoholes). (ii) SEM top-view image of nanholes and extinction peak
values of LSPR spectra for surface modifications. (iii) Nanoholes
arrays consisting of TiO2/Au/TiO2 films are
specifically modified with poly-l-lysine–poly(ethylene
glycol) (PLL–PEG) and thiolated PEG (HS-PEG) molecules for
site-specific surface functionalization. Adapted with permission from
ref (155). Copyright
2010 American Chemical Society.
Polymer-mediated surface functionalization is another interesting
strategy to generate a support layer for the immobilization of biorecognition
elements. Polymers play a vital role to enhance the reliability and
sensitivity of biosensors, and they are often used for hybridization
with plasmonic nanoparticles (Figure 7B(i)).
150
For instance, a polymer-assisted plasmonic
sensor was developed by hybridizing polyelectrolyte multilayers (PEMs)
with gold nanoparticles to real-time monitor the binding of antigen–antibody
on plasmonic sensors (Figure 7B(i)).
150
This hybrid film presented a stable and reliable
nanoporous structure under physiological conditions and enhanced the
surface area for bioconjugation and recognition.
150
Further, PEMs exhibited an antifouling property to prevent
nonspecific binding of proteins and cells that enhanced detection
sensitivity.
150
To utilize dynamic structure
of polymers, thermoresponsive poly(N-isopropylacrylamide)
(pNIPAAm)-based hydrogel was implemented as SPR sensors for rapid
tuning of SPR signal (Figure 7B(ii)).
151
Here, an indium tin oxide microheater was embedded
under the SPR sensor, and thus, rapid thermal response (i.e., swelling
and collapse) of pNIPAAm was evaluated (Figure 7B(ii)).
151
Thermal response of pNIPAAm
led to large refractive index changes and a high thermo-optical coefficient
of dn/dT = 2 × 10–2 RIU/K.
151
Further, polymers can be modified
with biorecognition elements for specific capture of target molecules,
and thus, a 3D binding matrix can be developed for biosensing applications
by utilizing dynamic and functional structure of polymers.
151,ref153,ref154
Recently, the researchers
have taken advantage of the plasmonic
surface geometry for surface functionalization. Patterned nanoplasmonic
structures with specialized geometries (e.g., holes and edges) exhibit
a potential to be used for site-specific surface modifications that
can increase the utility and specificity of nanoplasmonic platforms.
141b
Particularly, nanoplasmonic platforms employ
noble metal surfaces (e.g., gold and silver) that can be modified
using thiol chemistry to immobilize biorecognition elements.
152
Thiol chemistry also presents a broad range
of variety in length, saturation degree, and terminal groups to preferably
immobilize recognition elements (e.g., proteins, nucleotides, and
carbohydrates) in plasmonically active zones.
141b,153
The thiol exchange process is an interesting strategy to selectively
immobilize antibodies on the edges of triangular gold nanoplates that
are used for LSPR sensing platform.
141a
The thiols located on the edges of the nanoplates are more attractive
to exchange with the thiols in solution than the ones located on the
flat surfaces of the nanoplates due to decreased steric hindrance
at high-curvature sites.
141b,154
Other than patterned
nanoplasmonic structures, hybrid noble metal layers can also be selectively
functionalized for biosensing platforms (Figure 7C). Recently, nanohole arrays consisting
of TiO2/Au/TiO2 films were specifically modified with poly-l-lysine–poly(ethylene
glycol) (PLL–PEG) and thiolated PEG (HS-PEG) molecules (Figure 7C(i,ii)).
155
PLL–PEG
selectively adsorbed to the TiO2 layers (i.e., top and
bottom layers), and HS-PEG covalently bound to gold layer (i.e., intersectional
layer) (Figure 7C(iii)).
155
HS-PEG molecules were then functionalized with biotin for
the selective detection of avidin on the hole sidewalls (Figure 7C(iii)).
155
This site-specific
functionalization mechanism enabled the increase of the signal change
per unit time for avidin–biotin binding nearly 20-fold (Figure 7C(iii)).
155
In the future,
this functionalization strategy will play a key role for the improvement
of sensitivity and the development of multiplex assays by enabling
specific modifications on plasmonically active sites. Overall, surface
functionalization is one of the key parameters to develop a sensitive,
reliable, and accurate biosensing platform.
5
Applications of Plasmonic-Based Technologies
for POC: SPR, LSPR, and SPRi
5.1
SPR
SPR has been used in a broad
range of biosensing applications, including detection of bacteria,
viruses, eukaryotic cells, nucleic acids, peptide nucleic acids, proteins,
and drugs, and in monitoring of biomolecular interactions such as
nucleic acid hybridization or protein–ligand interaction.
54
Another important potential clinical application
of SPR is in cancer diagnosis. Cancer is a significant problem both
in the developed and developing world.
156
In 2008, ∼12.7 million cancer cases and 7.6 million cancer
deaths occurred worldwide, and 56% of the cases and 64% of the deaths
were reported in developing countries.
156
Although overall cancer incidence rates in developed countries are
higher than those observed in developing countries, cancer mortality
rates are usually similar between developed and developing countries.
156,157
Some of the most critical cancers in the developing world are female
breast (27.3%), stomach (15.3%), lung (19.1%), colorectal (10.7%),
and cervical (17.8%) cancers.
158
Early
detection of cancer is a critical need in medicine, especially for
cancer types such as breast, cervical, ovarian, and colorectal cancers.
157,159
Rapid available technologies to monitor early cancer markers supported
by our advanced understanding of cancer and discovery of specific
biomarkers will enhance the capabilities in cancer detection. Detection
platform technologies could serve diverse clinical needs in early
cancer detection and diagnosis (for instance by detecting circulating
tumor cells
160
) or monitoring cancer treatment.
In addition, these platforms could be inexpensive, rapid, portable,
and easy to operate in developing countries as well as in developed
settings, creating potentially broad screening tools for applicable
cancer types. From a diagnostic perspective, detection of circulating
biomarkers for cancer diagnosis is an interesting application of SPR-based
detection platforms. For instance, cytokine interleukin-8 (IL-8) plays
a crucial role in human cancer.
161
The
differentiations in IL-8 expression level result in multiple human
cancers, such as breast cancer, Hodgkin’s lymphoma, and prostate
cancer.
161
IL-8 concentration in saliva
was shown to be elevated in oropharyngeal squamous cell carcinoma
(OSCC) patients.
162
To detect the IL-8
concentrations in human saliva, a microfluidic SPR-based immunoassay
platform was developed.
163
For this experiment,
two monoclonal antibodies were used as a sandwich assay to detect
different epitopes on the antigen (IL-8) in either buffer or saliva
samples. This platform presented a 250 pM limit-of-detection in saliva
environment.
163
IL-8 levels in healthy
individuals saliva are 30 pM whereas the levels in oral cancer patients’
saliva are 86 pM.
163
By preconcentrating
the saliva in sample preparation steps, the system could potentially
be used in diagnostics as well.
Another attractive biomarker
detection experiment was performed
for prostate-specific antigen (PSA). The increase in the levels of
PSA (>4 ng/mL) in patient samples is one of the symptoms for possible
prostate malignancy.
164
On the other hand,
PSA has been reported as a potential marker for breast cancer in women.
165
To detect PSA levels a sandwich bioassay was
developed.
166
Basically, anti-PSA antibodies
were immobilized on the Au layer of the sensor surface. After the
sampling, Au nanoparticles coated with a secondary antibody were applied
to increase the SPR signal levels. In one experiment, 300 fM of PSA
in PBS was detected using 20 nm Au nanoparticles.
166
In a similar study, different sizes of Au nanoparticles
were evaluated in serum samples. For 20 and 40 nm Au nanoparticles,
limit-of-detection was observed as 2.3 and 0.29 ng/mL (8.5 pM) in
human serum, respectively.
167
The latter
detection limit is reported to cover the threshold value required
for diagnosing prostate cancer.
167
A portable microfluidic-based SPR device was developed for analysis
of antibiotics in milk. A disposable microfluidic cartridge incorporating
six microchannels used in this device is illustrated in Figure 8A.
168
The chips were
activated with self-assembled monolayers and then biofunctionalized
to detect samples from fluoroquinolone, sulfonamide, and phenicol
antibiotic families. The detection limit of the antibiotics in the
former antibiotic families was around 2 μg/L with milk diluted
by one-fifth in PBS, which is lower than the minimum required level
(MRL) set by European Union regulations. The detection limit for the
latter family was found to be 1.1 μg/L, which is slightly over
the MRL of 0.3 μg/L. The platform does not require any sample
preprocessing except dilution, and the process assay time is reported
to take ∼30 min per sample.
Figure 8
Portable SPR biosensor platforms. (A)
A multichannel cartridge
to be used for on-site antibiotic detection in milk samples. Reprinted
with permission from ref (168). Copyright 2010 Elsevier. (B) Portable SPR biosensor
prototype
to be used with microfluidic chips. Reprinted with permission from
ref (169). Copyright
2009 Elsevier. (C) Portable microfluidic-based device for cardiac
marker detection. Reprinted with permission from ref (170). Copyright 2006 American
Chemical Society.
A prototype hand-held
SPR-based device was developed and applied
to biotoxin detection (Figure 8B).
169
The device incorporated a plastic flow cell
as the detection medium, which can be replaced by a microfluidic chip
in future versions. A photodiode array was used to capture the reflected
light from the prism used in the Kretschmann configuration. The system
detected ricin, a highly toxic protein, with a 200 ng/mL limit of
detection compared to the 10 ng/mL performance of a commercial Biacore
device. The main advantages of the system are its portability and
battery operability, which are significant needs for POC diagnostics
in resource-constrained settings.
Researchers have also followed
the path of modifying some of the
available commercial SPR devices for biosensing applications. For
instance, SPR equipment (NTT Advanced, Tokyo, Japan) setup in the
Kretschmann configuration was arranged to work with a polydimethylsiloxane
(PDMS) microfluidic chip for the detection of B-type natriuretic peptide
(BNP) as a cardiac biomarker.
170
The researchers
developed a sensitive labeled immunoassay to be used in a portable
SPR device. A detection level of 10 pg/mL in serum was demonstrated.
170
It is reported that the patient blood BNP levels
range from ∼20 pg/mL to 2 ng/mL; therefore, the platform could
potentially be useful for clinical use.
170
This device is illustrated in Figure 8C.
Another example to this strategy is demonstrated by the modification
of a Spreeta 2000 device (Texas Instruments) to develop a portable
24-analyte biosensor.
171
5.2
Localized Surface Plasmon Resonance
LSPR has been used
in measurements of binding kinetics,
83a,172
conformational
changes,
173
and molecular
sensors,
174
and it is further exploited
in nanoscale photonics.
175
The solution-phase
nanoparticle sensing takes advantage of the dipole interactions between
the nanoparticles when attached to target molecules. For example,
when nanoparticles are hybridized to DNA targets and brought closer
in solution, the LSPR modes of gold nanoparticles are coupled, and
an enhanced extinction is observed. Distinguishing DNA target sequences
that contain single nucleotide mismatches or deletions has been possible
with this method, and an increase of sensitivity of 2 orders of magnitude
compared to fluorescence-based assays has been reported.
176
Since this mode coupling is a function of distance
between nanoparticles, it is possible to measure DNA strand lengths.
173a,177
An alternative path is to synthesize arrays of nanoparticles
on solid substrates and tailor their properties to optimize the extinction.
Nanosphere lithography (NSL) is a rapid self-assembly chemical synthesis
technique providing a cost-effective alternative to conventional lithographical
techniques for creating periodic array structures. The challenge in
this technique is the limitation of long-range defect-free layer production.
In general, 10–100 μm2 defect-free layers
are possible.
178
Efforts to increase the
defect-free synthesis range are continuing; e.g., large area defect-free
nanohole arrays fabricated by NSL have been demonstrated.
179
Briefly, single or double layer ordered hexagonal
arrays of polymer nanospheres are self-assembled on the substrate.
Then, a metal layer is deposited on the nanosphere mask by thermal
evaporation, pulsed laser deposition, or electron beam deposition.
The interstices between the nanospheres allow some of the metal to
reach to the substrate, creating an array of metal nanoparticles on
the surface. Finally, the nanosphere layer(s) is/are removed by sonicating
the sample in a solvent.
178
With variants
of this technique, a wide variety of nanoshapes were fabricated in
array format, including prisms, cubes, triangles, disks, and pyramidal
structures.
79
An earlier use of LSPR
for clinical purposes has been through the
detection and confirmation of a biomarker related to Alzheimer’s
disease.
180
LSPR spectroscopy was used
to detect the interactions of the amyloid-derived diffusible ligand
(ADDL) biomarkers with anti-ADDL antibodies. First, an array of Ag
particles (∼90 nm in width, ∼25 nm in height) was synthesized
on the substrate using the NSL technique described above. Then, the
nanoparticles were activated with the first anti-ADDL antibody of
a sandwich assay while also blocking the Ag particles for nonspecific
binding. Samples were exposed to various concentrations of ADDLs.
Finally, the sample was incubated in the second anti-ADDL antibody
to improve the extinction signal. UV–vis spectroscopy was used
to monitor the extinction signal. The experiments on cerebrospinal
fluid from patients with Alzheimer’s disease showed an LSPR
extinction signal shift with respect to the control patients. The
experiment supported previous observations of elevated ADDL concentrations
in the cerebral fluids of patients with Alzheimer’s disease
and demonstrated the potential of LSPR in medical applications.
Further examples of LSPR biosensing were given in peptide nucleic
acid–DNA hybridization,
181
label-free
DNA biosensing,
182
streptavidin–biotin
interactions on gold nanorods,
183
aptamer–protein
interactions,
184
and in detection of Escherichia coli,
185
PSA,
186
serum p53 protein, which is involved in head
and neck squamous cell carcinomas,
187
and
p53 gene mutation.
188
Further, LSPR
has applications in cancer diagnosis. An LSPR experiment
utilizing a microspectrometer to detect oral epithelial cancer cells
has been demonstrated.
189
The researchers
used two epithelial malignant cell lines of human oral squamous cell
carcinoma, HOC 313 clone 8 and HSC 3, and one nonmalignant cell line,
HaCaT, human keratinocytes. The LSPR spectra from colloidal gold nanoparticles
conjugated to monoclonal antiepidermal growth factor receptor (anti-EGFR)
antibodies after incubation in cell cultures with the HaCaT cell line
and the two malignant oral epithelial cell lines were measured. LSPR
scattering images were also acquired by dark-field microscopy and
used to demonstrate that antibody conjugated gold nanoparticles homogenously
and specifically attached on the malignant cell surfaces, whereas
the nanoparticles nonspecifically and randomly bound to HaCaT cell
surfaces. Thus, both the extinction measurements and the dark-field
images were shown to be potentially useful in cancer diagnostics.
Diagnostic LSPR applications for infectious diseases are also being
developed. A recent LSPR application was reported to capture, detect,
and quantify multiple HIV subtypes (A, B, C, D, E, G, and subtype
panel) from unprocessed whole blood and phosphate-buffered saline
(PBS) without any sample preprocessing.
55
In this study, polystyrene surfaces were first coated with poly-l-lysine molecules
to immobilize gold nanoparticles. Then, specific
surface chemistry was utilized to capture multiple HIV subtypes spiked
in whole blood and PBS samples, and the limit-of-detection was observed
down to 98 ± 39 virus copies/mL for HIV subtype D. Further, the
nanoplasmonic platform was validated with eight HIV-infected anonymous
discarded patient whole blood samples, and LSPR response was converted
to viral load in order to correlate with gold standard method (i.e.,
RT-qPCR) using Bland–Altman analysis. This statistical analysis
between the nanoplasmonic platform and RT-qPCR counts displayed that
there was no evidence for a systematic bias for HIV-infected patient
blood samples. To evaluate the repeatability of the presented platform,
a repeatability parameter was defined as the percent variation in
wavelength shift values for the same virus concentration, and the
platform presented a high repeatability (up to 90%), sensitivity,
and specificity to capture multiple HIV subtypes from unprocessed
whole blood and whole blood samples from HIV-infected patients. This
nanoplasmonic technology presented a versatile, broadly applicable
platform, which is capable of detecting other pathogens with reasonably
well-described biomarkers available, and could be performed at multiple
settings including POC settings and primary care settings.
Microfluidic-based
platforms are being developed for multiplexed
analysis of various biomarkers. An LSPR-based multiarray nanochip
for massively parallel detection was reported (Figure 9).
190
The nanochip was constructed
by a core–shell structured nanoparticle layer. Surface-modified,
100-nm-diameter silica nanoparticles were sandwiched between two layers
of gold deposited by thermal deposition. Glass slides were used as
substrates for gold deposition. The bottom layer was made of 5-nm-thick
chromium and 40-nm-thick gold layers, and the layer on top of the
silica was made of a 30-nm-thick gold layer. Specific antibodies were
then immobilized on the 300 spots each with a 100 nL volume, using
a nanoliter dispensing system. In this work, six different antibodies
on 50 spots each were immobilized. After 30 min incubation with six
antigens of varying concentrations, immunoglobulins A, D, G, and M
(IgA, IgD, IgG, and IgM); C-reactive protein (CRP); and fibrinogen
were detected by an LSPR setup operating in the reflection mode. It
should be noted that the measurements were absorbance intensity changes
in the peak wavelength instead of the more common wavelength shifts.
A sensitivity of 100 pg/mL for all proteins and a linear signal dependence
up to 1 μg/mL were reported. This easy-to-operate, multiplexed,
rapid technique has prospects in future POC technologies when applied
to various biomarkers.
Figure 9
The distribution of six different antibodies corresponding
to nine
concentrations from 1 fg/mL to 1 mg/mL is shown along with the reflection-mode,
intensity-based LSPR detection method. Reprinted with permission from
ref (190). Copyright
2006 American Chemical Society.
Another LSPR-based biosensor with fully integrated microfluidics
is shown in Figure 10.
191
The platform comprises a gold-nanoparticle-coated quartz
surface for the sensor channel and a blank quartz surface without
nanoparticles serving as the reference channel. The diameter of gold
nanoparticles was optimized with three-dimensional finite-difference
time-domain (3-D FDTD) simulations. The gold nanoparticles were immobilized
on the sample channel substrate by using silane modification. In this
platform, the binding of biotin to antibiotin antibody was evaluated.
The immobilization of biotin on a self-assembled monolayer of thiol
and the following binding of antibiotin were monitored in real-time
by the LSPR signal. A 530 nm LED was used as the light source, and
a photodiode was used as the detector. The collimated and focused
light incident on the sample channel excites LSPR modes of the gold
nanoparticles, and the remaining light transmitted to the photodiode
was used to collect real-time binding analysis data. A resolution
of 10–4 in refractive index corresponding to an
antibiotin detection limit of 270 ng/mL was achieved. The resolution
of the microfluidic LSPR system was comparable to that of conventional
LSPR biosensors.
72
Generalization of this
system to other biomolecules is possible, and with a versatile and
compact design, it has many prospects in various POC settings.
Figure 10
A microfluidic-based
LSPR system. (A) The gold-nanosphere-coated
LSPR channel and the control channel are positioned next to each other
in the photograph of the microchip. (B) The experimental schematic
indicating the LED light source, microfluidic chip, and photodetector.
(C) Atomic force microscopy (AFM) and transmission electron microscopy
(TEM) images of the nanoparticles on the chip. Reprinted with permission
from ref (191). Copyright
2009 Springer.
5.3
Surface
Plasmon Resonance Imaging (SPRi)
The early demonstrations
of SPRi aimed at providing better resolution
over microscopic techniques such as phase contrast microscopy or interference
contrast microscopy.
192
SPRi is a high-throughput
optical detection method similar to the sensogram-based SPR techniques
in principle, but the detection step allows imaging potentially tens
of channels in parallel. A monochromatic or narrow-pass filtered light
passing through a prism, which is typically configured in the Kretschmann
configuration, is incident on the activated thin metal surface close
to the surface plasmon resonance angle. Binding of the analytes will
induce a refractive index change in a vicinity close to the metal,
allowing for the incoming light to couple to the surface plasmon modes
and lose some energy to the propagating surface plasmon polaritons.
This energy loss will be observed as a change in the intensity of
the reflected light. Since the binding to activated sites on the metal
causes local refractive index changes, this spatial information will
be transferred to the reflected light. Thus, the captured images will
allow for temporal and spatial monitoring of surface binding events
in a label-free setup, allowing for adsorption and desorption kinetic
measurements and highly sensitive biorecognition experiments.
193
Earlier reported work in this area was
in analyzing nucleic acid hybridization, enzyme kinetics, and protein–DNA
interactions.
194
Surface functionalization
techniques for high-throughput array-based SPRi detection, involving
carbohydrate–protein interactions, protein–peptide interactions,
and protein–protein interactions, were developed.
195
RNA hybridization on DNA surface arrays was
shown, at around 10 nM detection limit.
196
With enzyme amplification using RNase H, the detection limit was
improved from 1 nM to ∼1 fM for DNA hybridization on RNA microarrays.
197
The technique utilizes the fact that RNase
H enzyme selectively and repeatedly destroys RNA from the DNA–RNA
heteroduplexes on gold surfaces, releasing the DNA back into the solution
and resulting in a six orders of magnitude improvement in the detection
limit.
Enzyme reactions have been observed with SPRi, such as
the base
excision repair (BER) reaction and the activity of the DNA N-glycosylases enzyme.
This enzyme is crucial in the major
mechanism of the nucleobase error correction mechanism, since a decrease
in its activity leads to carcinogenesis and aging.
198
An SPRi experiment reported the recognition of several
damaged DNA nucleobases and the screening for inhibitors of DNA repair
proteins.
199
Aptamers, natural or engineered
nucleic acids and peptides, have also been used in conjunction with
the SPRi technique. For instance, in aptamer–protein interaction
studies, detection platforms for human factor IXa,
200
vascular endothelial growth factor,
201
and human immunoglobin E
202
were
reported.
An SPRi system with a HeNe laser as a light source
was developed
to study the protein-binding kinetics of double-stranded DNA on a
10 × 12 array of planar gold surface. Using this system, a refractive
index change of 1.8 × 10–5 RIU was observed.
203
The improvement of this system led to the detection
of an effective refractive index change of 5 × 10–6 RIU on a 300 spot protein array
with 200 μm spot size and
1 s temporal resolution.
204
Another SPRi
system based on a tunable light source was shown to be sensitive to
a refractive index change of 3 × 10–5 RIU.
205
The imaging technique was investigated with
a polarization contrast approach to acquire high-contrast images.
This was accomplished by filtering the light reflected from the inactive
areas. This system showed a sensitivity of around 3 × 10–6 RIU in refractrometric
experiments, and the sensor
could provide 64 simultaneous measurements with a limit of detection
of 100 pM for 23-mer oligonucleotides.
206
Recently, high-throughput and integrated microfluidic applications
of SPRi have gained considerable attention. These systems provide
the integration of various elements required for the on-chip applications.
For example, a microfluidic chip with microchannels, microvalves,
micropumps, flow sensors, and an on-chip temperature controller was
developed with MEMS technology. The chip comprised three layers of
PDMS, carrying these structures on a glass substrate. The system has
been demonstrated through the detection of interaction between IgG
and antirabbit IgG, and a detection limit of 1 × 10–4 mg/mL (0.67 nM) was observed.
207
SPRi measurements of antibody arrays for larger molecules, such
as mouse KIAA proteins (MW ∼130 kDa)
208
and proteins in cell lysates,
209
bovine
serum albumin (MW ∼69 kDa), and bovine IgG (MW ∼150
kDa),
210
were followed by measurements
for lighter biomarkers (MW ∼10 kDa). For instance, a high-density
multiplexed antibody array was combined with the SPRi technique, to
detect low molecular weight protein biomarkers (Figure 11).
211
One-step carbonyldiimidazole
(CDI) surface chemistry was used to attach β2-microglobulin
(MW ∼11.8 kDa) and cystatin C (MW 13.4 kDa) biomarkers on functionalized
gold surfaces. The created antibody microarray comprised array element
sizes between 750 μm and 200 μm. The SPRi system was able
to detect these biomarkers with a sensitivity of down to ∼1
nM.
Figure 11
SPRi detection of 50 nM β2-microglobulin (β2m) and 100 nM cystatin C (cysC). (A and
C) Images for β2m and cysC detection, respectively. (B) The line profiles
indicated in parts A and C show signal only in the corresponding channels
where the antibodies were positioned. (D) Map of the antibodies and
control channels used in parts A and C. Reprinted with permission
from ref (211). Copyright
2006 American Chemical Society.
A recent advance is the development of a microfluidic chip
for
immunoassay-based SPRi.
212
The system,
shown in Figure 12, was comprised of two levels.
The “flow channel” level was comprised of a crossed-flow
architecture, allowing for loading two sets of reagents simultaneously.
A second level, the “control channel”, hosted microfluidic
pumps for controlling the liquid flow in the flow channel. The lower
layer crossed-channels have a width of 100 μm and a height of
∼10 μm, and their intersection is located over surface-activated
gold spots with 250 μm diameters and ∼50 nm thickness,
where the immunoreactions take place. These layers were fabricated
through photolithographic techniques on PDMS and were attached to
each other with the dipping–attaching method.
213
In the setup, p-polarized incoming light (625 nm) passes
through a prism and hits on the gold areas. The reflected light emerges
from the prism and is collected by a home-made digital imaging device.
To demonstrate the detection performance of the chip, first a one-step
immunoassay examined the binding of anti-biotin antibodies to biotinylated
bovine serum albumin (biotin–BSA), as an antibody–antigen
pair. A group of biotin–BSA/BSA solutions with different concentrations
was injected in horizontal channels, resulting in adsorption of biotin–BSA/BSA
on the gold surfaces. Then, known concentrations of anti-biotin solutions
were injected in the vertical channels, creating immunoreactions with
the immobilized biotin–BSA. The immunocomplex formation was
related to both the biotin–BSA concentration on the surface
and to the anti-biotin antibody. Real-time immunoassay imaging allowed
for monitoring of each immunoreaction in about 10 min, and the system
attained a sub-nanomolar detection limit. Next, a two-level immunoassay
was utilized for signal amplification. Another antibody, anti-goat
IgG antibody, labeled with gold nanoparticles was delivered to the
gold spots. This improved the limit of detection down to ∼40
pM. With its small instrument dimensions of ∼2–3 cm
and with less than 100 pM detection performance as a microscale platform,
this SPR imaging system has potential for future POC applications.
Figure 12
A microfluidic-based
SPRi platform. (A) Schematic of the microchip
for the SPRi experiment. The lower layer is where the immunoreactions
take place, and the upper layer controls the fluid flow by microfluidic
pumps. (B) The microfluidic device with dyed fluids to illustrate
the microchannels. Figures are courtesy of Prof. Richard N. Zare.
To increase the unit addressing
capability in a crossed-flow geometry,
a microfluidic chip with individually addressable chambers was developed
(Figure 13).
214
The
design allows for parallel interrogation of multiple analytes with
multiple ligands on an SPRi setup. The chip has two levels similar
to the microchip developed in ref (212). The lower level contains the flow channels
(100 μm wide by 10 μm high) and the upper level contains
microvalves (100 μm wide by 150 μm long) isolating and
controlling the liquid flow and a micropump to pump the liquid. The
chip is comprised of six columns and an array of 11 groups each with
four chambers, totaling 264 chambers. To load an individual chamber,
first the liquid is gated to a four chamber group and then four chamber
valves open or close to address the liquid to an individual chamber.
After loading the required chambers, the valves for those chambers
are closed and the remaining liquid is washed out. With this method,
up to 264 different ligands can be immobilized in the system. The
chip also comprises a serial dilution network for analytes, allowing
dilutions of samples up to six different concentrations for interrogations.
Figure 13
Layout
of the element addressable microdevice for SPRi experiments,
depicting the 264 chamber microarray, accessed by various features,
such as a micropump, microvalves, micromixers, input/output channels,
and a row multiplexer. A detailed microarray is shown along the photograph
of the microfluidic chip. Figures are courtesy of Prof. Eric T. Lagally.
To test the performance of the
chip, a human α-thrombin immunoassay
was conducted. The biotinylated human α-thrombin was immobilized
in a predetermined manner, taking advantage of the element-addressability
of chambers. Antihuman α-thrombin antibody was injected at different
concentrations. The binding of the antibody and its kinetics were
successfully observed in the SPRi sensogram data. Further, two immunoassays
were simultaneously performed to demonstrate the multiplexed nature
of the chip. Human factor IX proteins were immobilized in 44 element-addressable
chambers and human α-thrombin proteins were immobilized in another
set of 44 element-addressable chambers. In addition, using fluorescent-labeled
antibodies in conjunction with SPRi sensograms, the ability to recover
bound species from individual chambers was demonstrated. This SPRi
device architecture could be used in future high-throughput medical
applications.
An important SPRi advance recently reported individual
virus particle
detection. An SPRi device was developed, based on the Kretschmann
configuration, that incorporated a high numerical aperture (NA = 1.65)
objective to image single viruses.
215
An
SPR chip was placed on the objective with index matching oil, as shown
in Figure 14. Then, 632.8 nm of laser light
from a HeNe laser or 680 nm superluminescence diode light was p-polarized
and inserted in the optical path to excite surface plasmons on the
gold surface. The SPRi images allowed the imaging of individual influenza
A virus binding events on antibody-functionalized gold surfaces. Nanoparticles
of known sizes and estimated refractive indices were used for calibration
curves, intensity–volume curves were plotted, and volumetric
information for the influenza A virus was extracted. Using the known
density of influenza A virus, diameter of the virus was calculated
as 109 ± 13 nm, corresponding to a mass of 0.80 ± 0.35 fg.
Human cytomegalovirus (HCMV) was also studied with the setup and the
virus diameter was extracted as 218 ± 10 nm, corresponding to
a mass of 6.5 ± 0.8 fg.
Figure 14
SPRi system used for individual virus particle
imaging. (A) The
schematic for the SPRi experiment utilizing an objective in the Kretschmann
configuration and an inverted microscope. (B) SPR images of the influenza
A virus in PBS buffer. Reprinted with permission from ref (215). Copyright 2010 National
Academy of Sciences.
6
Conclusion and Future Outlook
Plasmonic-based
biosensor technologies can be used in different
economic settings for diagnostic testing, such as (i) “high-income,
centralized”; (ii) “high-income, POC”; (iii)
“low-income, centralized”; and (iv) “low-income,
POC”.
4
High-income, POC is exemplified
by bedside diagnostic tests and disaster or bioemergency response
in developed countries. Low-income, POC can be rural health clinics
with basic infrastructure or isolated village health service providers.
These conditions impose different levels of constraints on diagnostic
device engineering and design. For instance, material choice, storage,
transportation, fluid control, sample mixing, and disposal need to
be tailored for targeted POC conditions and applications. Interdisciplinary
research efforts are beneficial to address all these issues for diagnostic
device design at the POC.
The research efforts in developing
technological platforms for
POC are positioned at the cross-roads of multiple disciplines. “Convergence”
of multiple research fields is emerging as a new paradigm in science,
indicating the synergy between engineering, physical sciences, and
life sciences.
216
Cross-disciplinary pollination
among chemistry, biology, electrical engineering, optics, and biotechnology
is transforming each field and creating new ways of doing engineering
and performing fundamental life science research, as well as providing
new potential clinical applications. The LOC devices with integrated
nanoplasmonic and microfluidic components, inexpensive fabrication
techniques, and reliable read-outs for portable commercial POC platforms
will be a part of this transformation. We believe that the progress
in the microfluidics field converging with optics, electronics, and
bioengineering will greatly enhance the human health through generating
inexpensive, rapid, portable, and sensitive platform technologies.
Future robust and easy-to-operate POC testing systems will also
support the personalized medicine efforts.
217
For instance, the development of reliable bedside technologies for
medical diagnosis of infectious diseases would have a great impact
in disease monitoring and control. The current bedside testing devices
are exemplified by disposable immunochromatographic strip tests.
7,218
Integrated microfluidic–plasmonic technologies can be potentially
utilized at the bedside for various diseases, including examples such
as hepatitis, sepsis, pneumonia, cancer, and AIDS. We envision that
these technologies will play an important role in infectious disease
detection and monitoring at the POC, bedside, and primary care settings.
Another area with an unmet diagnostic need is immunodiagnostics.
219
Detection of protein markers can help diagnose
conditions such as cancer, metabolic diseases, or cardiovascular diseases.
Technologies sensitive to these proteins can be used for monitoring
disease progression, therapy, or early diagnosis.
219
Other areas that could potentially benefit from the development
of microfluidic POC platforms include toxin monitoring, food safety,
drug discovery, and proteomics research.
18a
One of the challenges from a POC perspective has been transferring
prototype plasmonic-based technologies from the laboratory settings
to clinical use. In the case of LSPR, development of sensitive, portable,
and inexpensive spectrometers will assist this transformation. Portable
spectrometers are already becoming available in the market.
220
Periodic or quasi-periodic metal nanoarrays,
nanoholes, and nanoparticles with engineered electromagnetic field
enhancement properties can provide enhanced localized surface plasmon
excitation and detection capabilities.
70,221
The translation
of LSPR technologies depends on their compatibility with batch-fabrication
to enable inexpensive devices. Currently, nanohole or similar periodic
nanoarray systems require expensive lithographic methods that are
limited by throughput. Some of the recent LSPR approaches that use
self-assembly of gold nanoparticles, which are compatible with 96-well
and microfluidic chip systems, are promising for applications in infectious
disease and early cancer detection both in developed and developing
settings.
55
Therefore, future advances
in nanotechnology are likely to provide significant improvements in
LSPR-based biomedical devices.
SPR technology has been commercialized,
most notably by Biacore’s
and KSV Instruments’ SPR series. The technological challenges
effecting SPR-based technologies for POC diagnostic applications include
generating substrates that will present reproducible results from
batch to batch, integrating the systems for portability, and adapting
the systems for use with bodily fluids. Developing diagnostic platforms
that will operate at the POC will require adapting SPR-based technologies
to be used as a versatile, inexpensive, and portable platform. Flexible
substrates such as paper-based printed chips or microfluidic cartridges
operating with portable readers will help translating SPR devices.
Further, the electronics industry is consistently creating more affordable
and rapid optical detectors and improved networked devices. Recently,
smartphones spread around the world rapidly. Considering the possibilities
of using built-in sensors or cameras in smart phones as a part of
integrated microfluidics platforms, it is conceivable that the next-generation
SPR devices will penetrate into global markets and households. In
particular, smartphone penetration in Africa can be leveraged for
POC device distribution, where these devices can be utilized as a
reader component for biosensing applications.
225,226,227
We expect that microfluidic
platforms, plasmonic technologies,
and surface functionalization techniques integrated in reliable and
sensitive lab-chip applications will continue to serve clinical needs
and patients. The development of immunoassays and further integration
of these assays with microfluidic technologies and emerging portable
optical technologies have the potential to enable applications that
will benefit both the resource-constrained and the developed world
settings, targeting real world clinical problems and diseases including
cancer and infectious diseases.